Publication:
Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients

dc.contributor.authorMillares, Laura
dc.contributor.authorPascual, Sergi
dc.contributor.authorMonton, Concepcion
dc.contributor.authorGarcia-Nunez, Marian
dc.contributor.authorLalmolda, Cristina
dc.contributor.authorFaner, Rosa
dc.contributor.authorCasadevall, Carme
dc.contributor.authorSeto, Laia
dc.contributor.authorCapilla, Silvia
dc.contributor.authorMoreno, Amalia
dc.contributor.authorAngelica Castro-Acosta, Ady
dc.contributor.authorJose Alvarez-Martinez, Carlos
dc.contributor.authorSibila, Oriol
dc.contributor.authorPeces-Barba, German
dc.contributor.authorGarcía-Cosío, Borja
dc.contributor.authorAgusti, Alvar
dc.contributor.authorGea, Joaquim
dc.contributor.authorMonso, Eduard
dc.date.accessioned2024-09-10T13:06:53Z
dc.date.available2024-09-10T13:06:53Z
dc.date.issued2019-06-24
dc.description.abstractBackground: The respiratory microbiome is altered in COPD patients but its relationship with core components of the disease, such as the severity of airflow limitation, the frequency of exacerbations or the circulating levels of eosinophils, is unclear. Methods: Cross-sectional study comprising 72 clinically stable COPD patients (mean age 68 [SD 7.9] years; FEV1 48.7 [SD 20.1]% of reference) who provided spontaneous sputum samples for 16S rRNA gene amplification and sequencing. The microbiome composition was analysed with QIIME. Results: We observed that: (1) more severe airflow limitation was associated with reduced relative abundance (RA) of Treponema and an increase in Pseudomonas; (2) patients with 2 exacerbations the previous year showed a significantly different bacterial community with respect to non-exacerbators (p=0.014), with changes in 13 genera, including an increase of Pseudomonas, and finally, (3) peripheral eosinophils levels 2% were associated with more diverse microbiome [Chao1 224.51 (74.88) vs 277.39 (78.92) p=0.006; Shannon 3.94 (1.05) vs 4.54 (1.06) p=0.020], and a significant increase in the RAs of 20 genera. Conclusion: The respiratory microbiome in clinically stable COPD patients varies significantly according to the severity of airflow limitation, previous history of exacerbations and circulating eosinophils levels.en
dc.description.sponsorshipThis study was funded by FIS PI15/00167 and PI15/02042 from Instituto de Salud Carlos III (ISCIII), SAF 2014-54371 (FEDER) from Ministerio de Economia y Competitividad, Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR), Laboratorios Menarini S. A, Fundacio Pla Armengol and Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES). CIBERES is an initiative of the ISCIII.; This work was also supported by grants from Agencia de Gestio d'Ajuts Universitaris i de Recerca-Generalitat de Catalunya (2017 GRC-716).es_ES
dc.format.page112es_ES
dc.format.volume19es_ES
dc.identifier.citationMillares L, Pascual S, Monton C, Garcia-Nunez M, Lalmolda C, Faner R, et al. Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients. BMC Pulm Med. 2019 Jun 24;19:112.en
dc.identifier.doi10.1186/s12890-019-0867-x
dc.identifier.issn1471-2466
dc.identifier.journalBMC Pulmonary Medicinees_ES
dc.identifier.otherhttp://hdl.handle.net/20.500.13003/16297
dc.identifier.pubmedID31234826es_ES
dc.identifier.puiL628244679
dc.identifier.scopus2-s2.0-85068169882
dc.identifier.urihttps://hdl.handle.net/20.500.12105/22656
dc.identifier.wos472880900001
dc.language.isoengen
dc.publisherBioMed Central (BMC)
dc.relation.publisherversionhttps://dx.doi.org/10.1186/s12890-019-0867-xen
dc.rights.accessRightsopen accessen
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectBacterial community
dc.subjectDiversity
dc.subjectEosinophils
dc.subjectExacerbations
dc.subjectSputum
dc.subjectStable COPD
dc.subject.decsMicrobiota*
dc.subject.decsFemenino*
dc.subject.decsAnálisis Multivariante*
dc.subject.decsPulmón*
dc.subject.decsMasculino*
dc.subject.decsEstudios Transversales*
dc.subject.decsVolumen Espiratorio Forzado*
dc.subject.decsEnfermedad Pulmonar Obstructiva Crónica*
dc.subject.decsHumanos*
dc.subject.decsPersona de Mediana Edad*
dc.subject.decsEstudios Prospectivos*
dc.subject.decsARN Ribosómico 16S*
dc.subject.decsAnciano*
dc.subject.decsSistema Respiratorio*
dc.subject.decsÍndice de Severidad de la Enfermedad*
dc.subject.decsProgresión de la Enfermedad*
dc.subject.decsEosinófilos*
dc.subject.decsRecuento de Leucocitos*
dc.subject.decsEsputo*
dc.subject.meshDisease Progression*
dc.subject.meshEosinophils*
dc.subject.meshAged*
dc.subject.meshSputum*
dc.subject.meshLeukocyte Count*
dc.subject.meshPulmonary Disease, Chronic Obstructive*
dc.subject.meshHumans*
dc.subject.meshForced Expiratory Volume*
dc.subject.meshMiddle Aged*
dc.subject.meshCross-Sectional Studies*
dc.subject.meshLung*
dc.subject.meshMicrobiota*
dc.subject.meshMale*
dc.subject.meshMultivariate Analysis*
dc.subject.meshRespiratory System*
dc.subject.meshSeverity of Illness Index*
dc.subject.meshProspective Studies*
dc.subject.meshRNA, Ribosomal, 16S*
dc.subject.meshFemale*
dc.titleRelationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patientsen
dc.typeresearch articleen
dspace.entity.typePublication
relation.isPublisherOfPublication4fe896aa-347b-437b-a45b-95f4b60d9fd3
relation.isPublisherOfPublication.latestForDiscovery4fe896aa-347b-437b-a45b-95f4b60d9fd3

Files